Message from AASLD President on Nomenclature Implementation
As AASLD President, it is with immense pleasure and pride that I write to you today to inform you of the next steps for the...
Andrea Gossard, APRN, CNP, AF-AASLD
Hepatology Associates SIG Representative
Andrea Gossard, APRN, CNP, AF-AASLD
Andrea Gossard is a Certified Nurse Practitioner, an Associate Professor of Medicine and a Director of NP PA practice at Mayo Clinic in Rochester, Minnesota. Her clinical and research interests are focused on the diagnosis and management of cholestatic and autoimme liver diseases including Primary Sclerosing Cholangitis, Primary Biliary Cholangitis, and Autoimmune Hepatitis. She is an Associate Fellow of the American Association for the Study of Liver Disease (AASLD) and Chair of the Hepatology Associates Special Interest Group. In addition, she is a member of the American Gastroenterology Association (AGA) and the American College of Gastroenterology (ACG).
Andrea was one of the founding members of Gastroenterology and Hepatology for Advanced Practice Providers (GHAPP), an association led by Advanced Practice Providers (APPs) and committed to education and professional development of APPs. She remains on the Board of Trustees.
AASLD Statement Supporting Safety and Wellbeing of Transgender and Non-Conforming Members
The American Association for the Study of Liver Diseases (AASLD) acknowledges the important open letter by Rainbows in Gastro...
Multinational Liver Societies Announce New “Fatty” Liver Disease Nomenclature That Is Affirmative And Non-Stigmatizing
Steatotic liver disease (SLD) is the new overarching term with metabolic dysfunction-associated steatotic liver disease (MASLD)...
New MASLD Nomenclature
No more NAFLD! Steatotic Liver Disease is the overarching term; NAFLD is now MASLD.
AASLD Calls on Congress to Help Save Lives
The American Association for the Study of Liver Diseases (AASLD), the leading organization of scientists and health care...